Clinical analysis of lenvatinib therapy for unresectable thyroid cancer at Nagoya City University Hospital and related facilities

Author:

Takano Gaku1,Kawakita Daisuke2,Matoba Takuma2,Oguri Keisuke3,Murashima Akihiro2,Minohara Kiyoshi2,Tsuge Hiroshi4,Matsumura Ayano2,Hojo Wataru4,Tsukamoto Koji5,Harata Ikuma6,Maseki Shinichiro7,Ozawa Taijiro8,Mitsuya Shoji4,Moribe Kazuho9,Iwasaki Shinichi2

Affiliation:

1. Department of Otorhinolaryngology, Nagoya City University West Medical Center

2. Department of Otolaryngology, Head and Neck Surgery, Nagoya city University Graduate School of Medical Sciences

3. Department of Otorhinolaryngology, Konan Kosei Hospital

4. Department of Otorhinolaryngology, Anjo Kosei Hospital

5. Department of Otorhinolaryngology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital

6. Department of Otorhinolaryngology, Kainan Hospital

7. Department of Otorhinolaryngology, Toyota Kosei Hospital

8. Department of Otorhinolaryngology, Toyohashi Municipal Hospital

9. Department of Otorhinolaryngology, Ichinomiya Municipal Hospital

Publisher

Japan Society for Head and Neck Cancer

Subject

Oncology,Otorhinolaryngology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3